CG
NPSP

Clinton Group’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Clinton Group’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-8,235
Closed -$246K – 500
2014
Q1 		$246K Buy
+8,235
New +$284K 0.09% 295

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Clinton Group's NPSP Position: Q2 2014 in Review

Clinton Group sold out of NPS PHARMACEUTICALS INC (NPSP) in Q2 2014, closing a stake of 8,235 shares — an estimated $246K sold.

Clinton Group first reported a position in NPSP in Q1 2014 and held it in 1 quarter. The position peaked at $246K in Q1 2014. 215 funds tracked by Wall St. Rank hold NPSP as of Q2 2014.

  • Clinton Group reported no remaining NPS PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Clinton Group sold 8,235 NPS PHARMACEUTICALS INC shares in Q2 2014, an estimated $246K.
  • Clinton Group first reported a position in NPS PHARMACEUTICALS INC in Q1 2014 and held it in 1 quarter.
  • Clinton Group's NPS PHARMACEUTICALS INC position peaked at $246K in Q1 2014.
  • 215 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q2 2014.

Based on Clinton Group's 13F filing for Q2 2014, filed 14 Aug 2014.